Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

8.74
+0.04000.46%
Post-market: 8.740.00000.00%16:10 EDT
Volume:870.74K
Turnover:7.59M
Market Cap:1.59B
PE:-85.68
High:8.80
Open:8.66
Low:8.54
Close:8.70
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.47
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-163.70
PE(LYR):2,725.29

Loading ...

Xeris Taps CEO to Additionally Serve as Chairman

Dow Jones
·
Jun 30

Palvella Therapeutics Appoints Savara CEO Matt Pauls to Board of Directors

Reuters
·
Jun 30

Xeris Names CEO John Shannon Board Chair, Effective July 1, 2026

Reuters
·
Jun 30

Xeris Announces Updates to Its Board of Directors

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Marla Persky to Transition to Lead Independent Director

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Appoints John Shannon as Chair of the Board

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Gets Notice of Allowance From US Patent and Trademark Office for New KEVEYIS Patent

MT Newswires Live
·
Jun 12

Xeris Biopharma gets USPTO notice of allowance for Keveyis patent extending protection to 2039

Reuters
·
Jun 12

Analysts Are Bullish on Top Healthcare Stocks: Omnicell (OMCL), Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Jun 11

Xeris Biopharma announces private exchange of convertible notes

TIPRANKS
·
Jun 11

BRIEF-Xeris Biopharma Announces Private Exchange Of Convertible Notes

Reuters
·
Jun 11

Xeris Biopharma retires USD 23 million of 8% convertible notes in cash-and-stock exchange

Reuters
·
Jun 11

Xeris Biopharma Announces Private Exchange of Convertible Notes

THOMSON REUTERS
·
Jun 11

Xeris Biopharma - to Retire $23 Mln Principal of Notes for $23 Mln Cash and Shares

THOMSON REUTERS
·
Jun 11

Savara COO Robert Lutz to take CFO role as Lowrance steps down for health reasons

Reuters
·
Jun 09

Xeris Biopharma director Marla Persky sells 15,500 shares worth $91,433.95

Reuters
·
Jun 06

Xeris Biopharma director Barbara-Jean Anne Bormann-Kennedy sells 16,000 shares for $97,507.2

Reuters
·
Jun 06

Xeris Biopharma director John Johnson sells 15,000 shares worth $91,422

Reuters
·
Jun 06

Xeris Biopharma Chief Legal Officer Beth Hecht sells 16,667 shares for $100,980.82

Reuters
·
Jun 03

Xeris Pharmaceuticals (XERS) Receives a Buy from Barclays

TIPRANKS
·
May 14